June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Impact of CMS Data on Provider Utilization Patterns Among Ophthalmologists
Author Affiliations & Notes
  • Nader Moinfar
    Florida Retina Consultants, Longwood, Florida, United States
    University of Central Florida College of Medicine, Orlando, Florida, United States
  • Paul Lee
    Retina Consultants of Western New York, Buffalo, New York, United States
  • mariangela rivera
    Retina Consultants of Western New York, Buffalo, New York, United States
  • Rebecca Metzinger
    Retina Consultants of Western New York, Buffalo, New York, United States
  • Augustine Lee
    Pulmonology, Mayo Clinic, Jacksonville, Florida, United States
  • Footnotes
    Commercial Relationships   Nader Moinfar, Allergan (R); Paul Lee, None; mariangela rivera, None; Rebecca Metzinger, None; Augustine Lee, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5071. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nader Moinfar, Paul Lee, mariangela rivera, Rebecca Metzinger, Augustine Lee; Impact of CMS Data on Provider Utilization Patterns Among Ophthalmologists. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5071.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : In 2014, CMS released provider utilization data for 2012 . Data for 2014 was subsequently released in 2016 and it thus offers the opportunity to compare utilization pattern changes over this period of time. This project attempts to identify a relation between public data release and provider practice patterns.

Methods : The dataset covers 900,000 providers and 9 million transactions. Data for all three years was compiled into a single dataset using a combination of MongoDB, R and Hadoop. Additional data fields were added to reflect normalized data, such as number of treatments per patient for each code.

Results : 1. Impact on code utilization
Of the 765 available CPT codes in 2014:
446 codes decreased
319 codes increased
Of the 760 available CPT codes 2013:
393 codes decreased
367 codes increased
2. Between 2012 and 2014, ophthalmology ranked second among all specialties in
medicine in its cost to CMS. When part D is removed, ophthalmology ranked fifth
in 2012, and sixth in 2013 and 2014.
3. Paired t-test for comparison of means of number of treatments per patient
Shapiro test failed to reject the null hypothesis that the samples came from a normal
Difference of mean was statistically significant (t = -5.8012, df = 3895, p-value <2.2e-16).
95% confidence interval was -0.14 to -0.12. Mean of the differences was -0.13.

Conclusions : Comparing pre-treatment (2012 to 2013) to post-treatment data (2013-2014), there is an overall decrease in the number of codes whose utilization increased, and an increase in the number codes whose utilization decreased. The overall cost for ophthalmology increased over this time period; the cost per provider,however, decreased when excluding part D medications. The impact of Part D medications on ophthalmology-related expenditure is noteworthy.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.